Judges side with FDA in rejecting stem cell device

March 22, 2013

(AP)—A federal appeals court is siding with the Food and Drug Administration in a case brought by medical device maker Cytori, ruling that the agency was correct to reject fast-track approval for two company devices used to process adult stem cells.

Cytori makes the Celution and StemSource devices which separate from fat tissue using a combination of spinning motions and . The company asked the FDA to approve the devices using a fast-track pathway reserved for devices that are similar to products already on the market. Cytori argued that its devices are similar to devices used to process blood and bone marrow.

A three-judge panel said the FDA was right to reject that argument and to require the company to apply through a more rigorous process.

Explore further: FDA OKs HeartWare device for transplant patients


Related Stories

Recommended for you

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Mar 23, 2013
They will move to Mexico.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.